Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone
-
* Corresponding author: Linda B Piller lpiller@sph.uth.tmc.edu
Current Controlled Trials in Cardiovascular Medicine 2002, 3:10 doi:10.1186/1468-6708-3-10
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 23 Oct 2002 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 30 Oct 2002 |
| Resubmission - Version 3 | Manuscript | 12 Nov 2002 | |
| Resubmission - Version 4 | Manuscript | 14 Nov 2002 | |
| Published | 14 Nov 2002 |